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Abstract
Background: Potential functional allele A/T single nucleotide polymorphism (SNP) of Interleukin 8 (IL-8) promoter -251has
been implicated in gastric cancer risk.
Methods: We aimed to explore the role of A/T SNP of IL-8 -251 in the susceptibility to gastric cancer through a systematic
review and meta-analysis. Each initially included article was scored for quality appraisal. Desirable data were extracted and
registered into databases. Eighteen studies were ultimately eligible for the meta-analysis of IL-8 - 251 A/T SNP. We adopted
the most probably appropriate genetic model (codominant model). Potential sources of heterogeneity were sought out via
stratification and sensitivity analyses, and publication biases were estimated.
Results: Between IL-8 -251 AA genotype with gastric cancer risk, statistically significant association could be noted with
overall gastric cancer, evidently noted in Asians, witnessed in high quality subgroup, and apparently noted in intestinal-type
gastric cancer.
Conclusions: Our meta-analysis indicates that IL-8 -251 AA genotype is associated with the overall risk of developing gastric
cancer and may seem to be more susceptible to overall gastric cancer in Asian populations. IL-8 -251 AA genotype is more
associated with the intestinal-type gastric cancer. IL-8 -251 AA genotype is not associated with Helicobacter Pylori infection
status in our meta-analysis.
Impact: The analyses suggest that IL-8 -251 AA genotype may be an important biomarker of gastric cancer susceptibility for
Asians, especially for Chinese Han population, the assumption that needs to be further confirmed in future well-designed
studies in China.
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Introduction
Nowadays, worldwide gastric cancer incidence has decreased
but its mortality still ranks second [1]. In the midwestern rural
areas of China [2], gastric cancer still constitutes one of the most
lethal malignancies. As is widely known, infectious, dietary,
environmental, and genetic factors are implicated in gastric
carcinogenesis, but only a minority of persons exposed to risk
factors such as Helicobacter pylori infection ultimately develop gastric
cancer [3], which implies that host genetic susceptibility plays an
important role in developing gastric cancer. Such various
susceptibilities could be explained, in part, by single nucleotide
polymorphisms (SNPs) of susceptible genes [4,5].
IL-8, one of key members of the human a-chemokine subfamily,
acts as a potent chemoattractant and activator of neutrophils [6,7].
Highly expressed levels of IL-8 mRNA and protein were found in
gastric cancer cells [8,9]. It has recently been suggested that IL-8 is
closely related to the tumorigenesis, angiogenesis, adhesion,
invasion or metastasis of cancer [10–14]. The IL-8 gene, located
on chromosome 4q12-21, is 5.2 kb long and contains four exons
andthree introns.Inthe year2000,Hulletal.reporteda single A/T
SNP at position -251 numbering from the transcription start site in
the proximal promoter region and found that the IL-8 -251A allele
tended to be associated with increased IL-8 production [15]. Thus,
it could be extrapolated that IL-8 -251A allele may increase the risk
of developing cancer through the elevation of its IL-8 expression.
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e28083In 2004, Savage et al. published the first study indicating that
IL-8 -251A allele is associated with an increased risk for gastric
cardia cancer [16]. Since then, researchers have consecutively
reported associations of IL-8 -251 A/T SNP with the susceptibility
to gastric cancer, but with mixed or conflicting results [17–34]. Up
to now, there have been five relevant published meta-analysis
articles focusing on IL-8 -251 A/T SNP [35–39], among which
one [35] was published in Chinese. Two articles were dealt with
the meta-analyses on overall cancer susceptibilities rather than
gastric cancer susceptibility per se in details [38,39]. Unfortunate-
ly, those five meta-analyses all failed to adopt the most likely
appropriate genetic model, and thus the authentic values of
statistical results could be compromised.
Accordingly, the aim of our meta-analysis was to explore, using
the most appropriate genetic model, the role of Il-8 -251 A/T SNP
in the risk of developing gastric cancer and to identify possible
sources of heterogeneity among the eligible studies.
Materials and Methods
Search Strategy
A systematic literature search was performed for articles
regarding IL-8 -251 A/T SNP associated with the gastric cancer
risk. The MEDLINE, EMBASE databases, Chinese National
Knowledge Infrastructure (CNKI), Web of Science, and BIOSIS
databases were used simultaneously with the combination of terms
‘‘Interleukin 8’’, ‘‘IL-8’’, ‘‘interleukin’’, or ‘‘cytokine’’; ‘‘gene’’;
‘‘polymorphism’’, ‘‘variant’’, or ‘‘SNP’’; and ‘‘gastric cancer’’,
‘‘gastric carcinoma’’, ‘‘diffuse gastric cancer’’ or ‘‘stomach cancer’’
from January 2000 to January 2011. The search was performed
without any restriction on language. The scope of computerized
literature search was expanded according to the reference lists of
retrieved articles. The relevant original articles were also sought
manually.
Study Selection
Studies concerning the association of IL-8 -251 A/T SNP with
the risk of developing gastric cancer were included if the following
conditions were met: (i) any study described the association of IL-8
-251 A/T SNP with gastric cancer; (ii) any study reported the
numbers of both controls and gastric cancer cases; (iii) results were
expressed as odds ratio (OR) with 95% confidence intervals (CI);
and (iv) studies were case-control or nested case-control ones.
Methodological Quality Appraisal
To identify high-quality studies, we mainly adopted predefined
criteria for Quality Appraisal initially proposed by Thakkinstian et
al. [40], adapted by Camargo et al. [41], and refined by Xue et al.
[5,42]. The criteria (seen in Table S1 online) cover credibility of
controls, representativeness of cases, consolidation of gastric
cancer, genotyping examination, and association assessment.
Methodological quality was independently assessed by two
investigators (J. Liu and B. Lin). Disagreements were resolved
through discussion. Scores ranged from the lowest zero to the
highest ten. Articles with the score lower than 6.5 were considered
‘‘low-or-moderate quality’’ ones, whereas those no lower than 6.5
were thought of as ‘‘high quality’’ ones.
Data Extraction
The following data from each article were extracted: authors,
year of publication, country, ethnicity of participants (categorized
as Caucasians, Asians, etc.), study design, source of controls,
number of controls and of cases, genotyping method, distribution
of age and gender, Lauren’s classification (intestinal, diffuse, or
mixed), anatomical classification (cardia or non-cardia cancer) and
Helicobacter Pylori infection status.
The data were extracted and registered into two databases
independently by two investigators (J. Liu and B.Lin) who were
blind to journal names, institutions or fund grants. Any
discrepancy between these two investigators was resolved by the
investigator (H. Xue), who participated in the discussion with them
and made an ultimate decision.
Statistical Analysis
All statistical analyses were performed using STATA statistical
software (Version 10.1, STATA Corp, College Station, TX). Two-
sided Ps,0.05 were considered statistically significant.
Hardy-Weinberg equilibrium (HWE) in controls was calculated
again in our meta-analysis. The chi-square goodness of fit was used
to test deviation from HWE (significant at the 0.05 level).
Odds ratios (OR) and 95% confidence intervals (95% CI) were
used to assess the strength of associations between IL-8 -251 A/T
SNP and gastric cancer risk. OR1,O R 2, and OR3 regarding IL-8 -
251 A/T SNP were calculated for genotypes AA versus TT, TA
versus TT, and AA versus TA, respectively.
The above pairwise differences were used to determine the most
appropriate genetic model. If OR1=OR 3?1 and OR2=1, a
recessive model is suggested. If OR1=OR 2?1 and OR3=1, a
dominant model is implied. If OR2=1/OR3?1 and OR1=1, a
complete overdominant model is suggested. If OR1.OR2.1 and
OR1.OR3.1, or OR1,OR2,1 and OR1,OR3,1, a codom-
inant model is indicated [43]. If a dominant model was indicated,
the original grouping was collapsed and the new group of A
carriers (AA plus TA) was compared with TT genotype; if a
recessive model was suggested, AA was compared to the group of
TT plus TA; if a complete overdominant model was implied, the
group of AA plus TT was compared with TA; or if a codominant
model was insinuated, AA was compared with TA and with TT,
respectively.
The Q statistic was used to test for heterogeneity among the
studies included in the meta-analysis. A fixed-effects model, using
Mantel–Haenszel (M-H) method, was employed to calculate the
pooled ORs when homogeneity existed on the basis of Q-test p
value no less than 0.1.By contrast, a random-effects model, using
DerSimonian and Laird method (D+L), was utilized if there was
heterogeneity based on Q-test p value less than 0.1. The
significance of pooled ORs was tested by Z test (P,0.05 was
considered significant).
Sensitivity analysis was performed, in which the meta-analysis
estimates were computed after every one study being omitted in
each turn.
Finally, publication bias was assessed by performing funnel plots
qualitatively, and estimated by Begg’s and Egger’s tests quantita-
tively.
Results
Literature Search and Study Selection
After comprehensive searching, a total of 261 articles in English
and 8 in Chinese were retrieved. In our meta-analysis were initially
included altogether 19 studies [16–34] which catered to the
inclusion criteria. Those 19 studies were preliminarily appropriate
to the meta-analysis of the associations with gastric cancer
regarding IL-8 -251 A/T SNP. After careful reading of the full
text of those studies, we found two studies investigated by
seemingly different but actually almost the same authors [32,34],
so we only included the study with larger sample size (34), that is,
the study with smaller sample size [32] was finally excluded. The
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S. et al were changed into Song B. et al for correct citation.
Traditionally speaking, any study that deviated from HWE
should have been removed; however, Minelli C et al. recently
pointed out that studies that appear to deviate from HWE should
be investigated further rather than just excluded unless there are
other grounds for doubting the quality of the study [44]. To date,
it is still inconclusive whether studies deviated from HWE should
be included or excluded in conducting meta-analysis. In our meta-
analysis, one study [21] was deviated from HWE; however,
considering that the number of participants in this study was large
and given that sensitivity analyses would be conducted, we finally
remained this study in our meta-analysis.
Thus, 18 studies [16–31,33,34] with a total of 6554 controls and
4163 cases were ultimately eligible for the meta-analysis of IL-8 -
251 A/T SNP. The corresponding characteristics were seen in
Table 1. The flow chart of literature search and study selection
was illuminated in Figure 1.
Overall Meta-analysis and Subgroup Analyses
OR1 (p value), OR2 (p value), and OR3 (p value) of IL-8 -251
A/T SNP were 1.32 (p=0.018), 1.12 (p=0.082), and 1.17
(p=0.092), respectively, possibly insinuating a codominant model
effect of putative susceptible A allele (OR1.OR2.1 and
OR1.OR3.1). To further determine whether the adoption of
codominant genetic model is influenced by the study deviated
from HWE [21], the recalculated OR1 (p value), OR2 (p value),
and OR3 (p value) of IL-8 -251 A/T SNP, after the study [21] had
been removed, became 1.30 (p=0.032), 1.13 (p=0.094), and 1.15
(p=0.155), respectively, also possibly insinuating a codominant
model effect of putative susceptible A allele. Considering that the
participants in the study [21] were Asians, we calculated OR1 (p
value), OR2 (p value), and OR3 (p value) of IL-8 -251 A/T SNP
among Asian participants, with both the inclusion and the
exclusion of the study [21], and their values became 1.52 (1.16–
2.00, p=0.003), 1.19 (1.02–1.38, p=0.023), and 1.31 (1.04–1.66,
p=0.024) when the study [21] was included and 1.51 (1.12–2.02,
p=0.006), 1.19 (1.02–1.39, p=0.029), and 1.29 (1.00–1.67,
p=0.050) when the study [21] was excluded, definitely indicating
a codominant model effect of putative susceptible A allele among
Asians (OR1.OR2.1 and OR1.OR3.1 with almost all their p
values statistically significantly less than 0.05 or one just reached
0.05). Thus, the inclusion of the study with deviation from HWE
[21] does not influence the adoption of the most probable genetic
model (codominant model) in our meta-analysis. The genotype AA
was compared with the genotype TA (AA vs TA) and with the
genotype TT (AA vs TT), respectively. In Figure 2, for overall
gastric cancer no statistically significant finding could be observed
(AA vs TA), whereas a statistically significant finding could be
noted (AA vs TT) from the facts that the pooled OR (95% CI, p
value) was 1.17 (0.98–1.40, p=0.092) for the former but 1.32
(1.05–1.66, p=0.018) for the latter. The data were stratified, in
the light of the ethnicity of participants, into Caucasians, Asians,
and Hispanic. Also in Figure 2, the apparently opposite tendency
could be noted between Caucasians and Asians, and statistically
significant findings were noted in Asians but not in Caucasians
(AA vs TT). The pooled ORs (95% CIs, p value) were 1.52 (1.16–
2.00, p=0.003) and 0.83 (0.66–1.04, p=0.100) in Asians and
Caucasians (AA vs TT) or 1.31 (1.04–1.66, p=0.024) and 0.93
(0.76–1.13, p=0.453) in Asians and Caucasians (AA vs TA),
respectively. Although the pooled OR could not be appraised in
Hispanic participants, among which only one study was conducted
in that ethnicity [26], the ethnicity that should be treated as
Mexican or Hispanic rather than Caucasian [26,45], the
individual OR was still apparent, being 1.73 (0.77–3.85,
p=0.182) and 0.79 (0.40–1.54, p=0.484) in Figure 2. We further
sub-stratified Asians into the participants from China, Taiwan
China, Japan, Korea, and Iran. As in Figure 3, the apparently
discrepant tendency could be noted in the study from Taiwan
China [19], the individual OR (95% CIs, p value) of which was
0.52 (0.34–0.80, p=0.003); whereas the similar tendency could be
noted in the studies from China, Japan, and Korea, the ORs (95%
CIs, p value) of which were 1.71 (1.36–2.13, p=0.000), 1.37
(0.95–1.98, p=0.087), and 1.79 (1.23–2.59, p=0.002), thus
indicating statistically significant findings of increased risk for
participants in China or Korea (AA vs TT). Likewise, similar
findings were observed in the mode (AA vs TA), with 1.50 (1.22–
1.83, p=0.000), 1.06 (0.74–1.53, p=0.743), 1.36 (0.81–2.29,
p=0.246), and 0.62 (0.41–0.93, p=0.023) in China, Japan,
Korea, and Taiwan China, respectively. Also interestingly,
statistically significant finding was even more apparently noted
in Iran because the individual OR for Iran (95% CIs, p value) was
5.83 (1.63–20.89, p=0.007) and 5.05 (1.62–15.73, p=0.005) in
the mode (AA vs TT) and mode (AA vs TA), respectively.
As shown in Table 2 and Table 3, specific data for IL-8 -251 A/
T SNP were stratified, on the basis of sample size, into two
subgroups: large sample (the total number of controls and cases
not less than 500) and small-and-moderate sample (the total
number of controls and cases less than 500) subgroups. Statistically
significant finding was noted in small-and-moderate sample
subgroup but not in large sample counterpart (AA vs TT), given
that the pooled ORs (95% CIs, p value) were1.62 (1.25–2.10,
p=0.000) for the former and 1.16 (0.86–1.57, p=0.340) for the
latter, respectively.
The data were also stratified, in accordance with the quality
appraisal scores, into high quality (scores no less than 6.5) and low-
and-moderate quality (scores less than 6.5) subgroups. A
statistically significant finding was witnessed in high quality
subgroup but not in low-and-moderate quality counterpart, given
that the pooled ORs (95% CIs, p value) were 1.38 (1.07–1.78,
p=0.013) for the former and1.23 (0.77–1.97, p=0.388) for the
latter (AA vs TT), and 1.25 (1.03–1.51, p=0.023) for the former
and 1.03 (0.71–1.49, p=0.892) for the latter (AA vs TA),
respectively.
The data were additionally stratified, in line with publication
time, into the earlier publication subgroup (articles published
before or in 2005) and the later publication subgroup (articles
published after 2005). No statistically significant findings were
observed on the grounds that the pooled ORs (95% CIs, p value)
were 1.39 (0.85–2.28, p=0.191) in the former and 1.28 (0.99–
1.66, p=0.063) in the latter (AA vs TT), and 1.23 (0.82–1.85,
p=0.326) in the former and 1.13 (0.93–1.37, p=0.222) in the
latter (AA vs TA), respectively.
When gastric cancer was classified into non-cardia (or distal)
and cardia subtypes, no statistically significant findings were found
among non-cardia type or among cardia type on the grounds that
Figure 2. Odds ratios (ORs) for associations between IL-8 -251 A/T SNP and gastric cancer risk among different ethnicities, in order
of increasing publication year, 2004–2010. Studies were entered into the meta-analysis sequentially by year of publication. The sizes of the
squares indicate the relative weight of each study. Weights were derived from random-effects analysis. Bars, 95% confidence interval (CI). A) The IL-8 -
251 AA genotype versus TT genotype; B) The IL-8 -251 AA genotype versus TA genotype.
doi:10.1371/journal.pone.0028083.g002
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p=0.783) among non-cardia type and 1.20 (0.72–2.00, p=0.481)
among cardia type (AA vs TT), and 0.85 (0.70–1.04 p=0.122)
among non-cardia type and 1.22 (0.97–1.55, p=0.092) among
cardia type (AA vs TA).
In terms of pathology, gastric cancer could be classified into
intestinal, diffuse, or mixed subtypes, and a statistically significant
finding was observed in intestinal-type cancer but not in diffuse-
type cancer (AA vs TT), for the pooled ORs (95% CIs, p value)
were 1.37 (1.05–1.79, p=0.021) in the former and 1.24 (0.57–
2.70, p=0.595) in the latter (AA vs TT).
In terms of Helicobacter pylori infection status, no statistically
significant findings were found among Helicobacter pylori positive
cancer patients (compared with Helicobacter pylori positive controls)
or among Helicobacter pylori negative cancer patients (compared
with Helicobacter pylori negative controls), for pooled ORs (95% CIs,
p value) were 1.56 (0.76–3.21, p=0.230) in the former and 0.99
(0.59–1.65, p=0.967) in the latter (AA vs TT), and 1.22 (0.62–
2.43, p=0.564) in the former and 0.88 (0.57–1.38), p=0.589) in
the latter (AA vs TA), as shown in Figure 4.
And when genotyping techniques were considered, a statistically
significant finding was noted in other genotyping technique
subgroup but not in traditional PCR-RFLP subgroup (AA vs
TT). In the PCR-RFLP subgroup and in other genotyping
technique subgroup, pooled ORs (95% CIs, p value) were 1.28
(0.86–1.89, p=0.223) in the former and 1.34 (1.00–1.80,
p=0.048) in the latter (AA vs TT).
Sensitivity Analysis
Meta-analyses were conducted repeatedly when each particular
study had been removed. The results indicated that fixed-effects
estimates and/or random-effects estimates before and after the
deletion of each study were similar at large, suggesting high
stability of the meta-analysis results. As shown in Figure 5, the
most influencing single study on the overall pooled estimates
seemed to be the study conducted by Lee WP et al. [19], the
sensitivity analysis, however, indicated high stability of the results
from the facts that the ORs (95% CI, p value) were 1.32 (1.05–
1.66, p=0.018) before the removal of that study and 1.39 (1.13–
1.70, p=0.002) after the removal of that study (AA vs TT).
Cumulative Meta-analysis
Cumulative meta-analyses of IL-8 -251 A/T SNP association
were also conducted among Asians via the assortment of both total
number of sample size (Figure 6 part A) and publication time
(Figure 6 part B). As shown in Figure 6 part A, the inclinations,
though undulated, toward significant associations could be seen
when sorted by total sample size among Asians (AA vs TT). In
Figure 6 part B was shown the cumulative meta-analysis of
Figure 3. Odds ratios (ORs) for associations between IL-8 -251 A/T SNP and gastric cancer risk among geographically Asian
participants from China, Taiwan China, Japan, Korea, and Iran. The sizes of the squares indicate the relative weight of each study. Bars, 95%
confidence interval (CI). A) The IL-8 -251 AA genotype versus TT genotype; B) The IL-8 -251 AA genotype versus TA genotype.
doi:10.1371/journal.pone.0028083.g003
Table 2. Stratification for the test of heterogeneity on IL-8 -
251 AA vs TA based on a codominant model.
Q-test OR(95%CI) P value
chi-squared d.f. p
Overall 35.96 17 0.005 1.17(0.98–1.40) 0.092
Large sample 23.18 9 0.006 1.12 (0.90–1.40) 0.305
Small-and-moderate
sample
11.75 7 0.109 1.25 (0.98–1.59) 0.067
High quality 17.88 10 0.057 1.25 (1.03–1.51) 0.023
Low-and-moderate
quality
14.28 6 0.027 1.03 (0.71–1.49) 0.892
Publication before
or in 2005
17.20 5 0.004 1.23(0.82–1.85) 0.326
Publication after 2005 18.40 11 0.073 1.13 (0.93–1.37) 0.222
Caucasians 0.98 3 0.806 0.93 (0.76–1.13)
* 0.453
#
Asians 27.54 12 0.006 1.31 (1.04–1.66) 0.024
Non-cardia type 4.56 7 0.714 0.85 (0.70–1.04)
* 0.122
#
Cardia type 4.77 4 0.311 1.22 (0.97–1.55)
* 0.092
#
Intestinal type 4.96 6 0.549 1.08 (0.83–1.40)
* 0.583
#
Diffuse type 6.42 3 0.093 0.89 (0.52–1.53) 0.672
Hp positive 14.11 3 0.003 1.22 (0.62–2.43) 0.564
Hp negative 2.43 2 0.297 0.88 (0.57–1.38) 0.589
PCR-RFLP genotyping 12.46 6 0.052 1.07 (0.82–1.41) 0.607
Other genotyping 23.23 10 0.010 1.25 (0.97–1.61) 0.084
*: M-H ORs (95% CI), otherwise D+L ORs (95% CI).
#: P values of M-H estimates, otherwise P values of D+L estimates.
doi:10.1371/journal.pone.0028083.t002
Table 3. Stratification for the test of heterogeneity on IL-8 -
251 AA vs TT based on a codominant model.
Q-test OR(95%CI) P value
chi-
squared d.f. p
Overall 51.03 17 0.000 1.32 (1.05–1.66) 0.018
Large sample 38.78 9 0.000 1.16 (0.86–1.57) 0.340
Small-and-moderate
sample
6.08 7 0.530 1.62 (1.25–2.10)
* 0.000
#
High quality 27.54 10 0.002 1.38 (1.07–1.78) 0.013
Low-and-moderate quality20.36 6 0.002 1.23 (0.77–1.97) 0.388
Publication before or in
2005
22.46 5 0.000 1.39(0.85–2.28) 0.191
Publication after 2005 28.50 11 0.003 1.28 (0.99–1.66) 0.063
Caucasians 1.42 3 0.700 0.83 (0.66–1.04)
* 0.100
#
Asians 33.20 12 0.001 1.52 (1.16–2.00) 0.003
Non-cardia type 19.22 7 0.008 1.05 (0.73–1.51) 0.783
Cardia type 12.12 4 0.016 1.20 (0.72–2.00) 0.481
Intestinal type 7.00 6 0.321 1.37 (1.05–1.79)
* 0.021
#
Diffuse type 12.14 3 0.007 1.24 (0.57–2.70) 0.595
Hp positive 22.19 4 0.000 1.56 (0.76–3.21) 0.230
Hp negative 4.88 3 0.181 0.99 (0.59–1.65) 0.967
PCR-RFLP genotyping 24.26 6 0.000 1.28 (0.86–1.89) 0.223
Other genotyping 26.45 10 0.003 1.34 (1.00–1.80) 0.048
*: M-H ORs (95% CI), otherwise D+L ORs (95% CI).
#: P values of M-H estimates, otherwise P values of D+L estimates.
doi:10.1371/journal.pone.0028083.t003
Interleukin-8 Polymorphism and Gastric Cancer Risk
PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e28083Interleukin-8 Polymorphism and Gastric Cancer Risk
PLoS ONE | www.plosone.org 9 January 2012 | Volume 7 | Issue 1 | e28083association for IL-8 -251 A/T SNP with overall gastric cancer
among Asians in chronological order (AA vs TT).
Publication Bias Analysis
Publication bias was preliminarily examined by funnel plots
qualitatively and estimated by Begg’s and Egger’s tests quantita-
tively. Its funnel plot (Figure 7) showed that dots nearly
symmetrically distributed, predominantly within pseudo 95%
confidence limits (AA vs TA). P values were 0.198 (AA vs TT)
and 0.495 (AA vs TA) in Begg’s test, insinuating no publication
bias but p values were 0.031 (AA vs TT), insinuating a little
publication bias but 0.171 (AA vs TA) in Egger’s test, insinuating
no publication bias.
Discussion
In our meta-analysis, a statistically significant finding could be
noted (AA vs TT) with the overall risk of developing gastric cancer;
the apparently opposite tendency could be noted between
Caucasians and Asians, and statistically significant findings were
even more apparently noted in Asians, especially in Chinese Han
population, but not in Caucasians (AA vs TT). Our meta-analyses
suggest that IL-8 -251 AA genotype may be an important
biomarker of gastric cancer susceptibility for Asians, especially for
Chinese Han population, the assumption that needs to be further
confirmed in future well-designed studies in China.
Based on the findings of cumulative meta-analyses, the
inclinations, though undulated, toward significant associations in
Asians could be obviously seen when sorted by total sample size
(AA vs TT). The IL-8 -251 AA genotype may seem to be more
susceptible to gastric cancer in Asians. Thus, the different or even
conflicting risk associations, if so, among different ethnicities
should be further meticulously investigated and reconfirmed in the
future.
Our subgroup analyses also indicate that significant associations
could be found in the small-and-moderate sample subgroup but
not in the large sample counterpart (AA vs TT). In large sample
subgroup the influences of ORs in the studies conducted by Lee
et al. [19] and Kang et al. [30] are both oppositely strong enough
(0.52 and 2.12, respectively) to offset the overall OR, thus the
insignificant value (1.16) could be reached, whereas in small-and-
moderate sample subgroup the ORs are averagely distributed
around 1, but the influence of OR in the study conducted by
Kamali-Sarvestani et al. [22] is strong enough (5.83) to make the
overall OR to reach the significant value (1.62). A statistically
significant finding was also witnessed in high quality subgroup but
not in low-and-moderate quality counterpart (AA vs TT or AA vs
TA). It is natural that high-quality studies should be designed in
the future so as to accurately explore the real associations between
IL-8 -251 A/T SNP and gastric cancer.
Additionally, 8 [18–20,23,25–27,29] out of 18 eligible studies
were dealt with noncardia gastric cancer and 5 [16,18,19,27,33]
with cardia gastric cancer. No statistically significant findings could
be noted with either subgroup. 7 studies [18–20,25,26,29,30] in
our meta-analysis were dealt with pathologically intestinal-type
gastric cancer and 4 [18,19,26,30] out of 18 studies were dealt
with pathologically diffuse-type gastric cancer. A statistically
significant finding could be noted in intestinal-type but not in
Figure 4. Odds ratios (ORs) for associations between IL-8 -251 A/T SNP and gastric cancer risk with different H pylori infection
status. H pylori infection status includes H pylori positive cases versus positive controls and H pylori negative cases versus negative controls. The sizes
of the squares indicate the relative weight of each study. Bars, 95% confidence interval (CI). A) The IL-8 -251 AA genotype versus TT genotype; B) The
IL-8 -251 AA genotype versus TA genotype.
doi:10.1371/journal.pone.0028083.g004
Figure 5. Influence analysis of the summary odds ratio coefficients on the association for the IL-8 -251 AA genotype with gastric
cancer risk. Results were computed by omitting each study (on the left) in turn. Bars, 95% confidence interval. Meta-analysis random-effects
estimates (exponential form) were used.
doi:10.1371/journal.pone.0028083.g005
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cancer differs from noncardia-type gastric cancer in etiology,
pathology, carcinogenesis, and/or prognosis [46–48], so is
intestinal-type cancer versus diffuse-type cancer. It could be said
that the indiscriminate combination of cardia-type and noncardia-
type cases or intestinal-type and diffuse-type cases in the majority
of eligible studies may mask or at least underestimate the real
strength of the associations [5,42].
Furthermore, Helicobacter pylori infection is associated with
increased epithelial IL-8 expression and mucosal secretion of IL-
8 and Helicobacter pylori induced IL-8 expression in gastric epithelial
cells is associated H pylori with CagA positive phenotype [49]. In
our meta-analysis, no significant associations could be found
among Helicobacter pylori positive or negative cancer patients, which
is inconsistent with the finding reported by Liu et al. [37]. The
discrepancy could be explained that the study conducted by Lee et
al. [19] was finally included in the Helicobacter pylori infection
subgroup analysis in our meta-analysis but not in the meta-analysis
by Liu et al. revealed in their Fig. 2 [37], because the OR in the
study conducted by Lee et al. [19] is oppositely strong enough
(0.40) to offset the overall OR, thus the insignificant value (1.56)
could be reached. At any rate, the real association between
Helicobacter pylori infection status and IL-8 -251 A/T SNP should be
further meticulously investigated in the future.
With the advent of sophisticated genotyping technologies like
seminested polymerase chain reaction, TaqMan allelic discrimi-
nation test, or real-time PCR, we may witness an upsurge of
genetic association studies in the future. In our meta-analysis,
statistically significant finding could be noted in other genotyping
technique subgroups but not in conventional PCR-RFLP
subgroup. The difference should be concerned with caution. We
propose that the sensitivity and specificity of those genotyping
techniques need to be further explored so as to seek out the
optimal approaches which could minimize the genotyping errors
[5,42].
Up to now, two genome-wide association (GWA) studies related
to gastric cancer have been published [50,51]. They both reported
that common variants associated with the risk of esophageal
squamous cell carcinoma are also associated with the risk of cardia
gastric cancer, but neither of them found IL-8 to be a risk gene of
gastric cancer. Our explanation of the discrepancy is that the
common initial stage of those two GWA studies focuses merely on
esophageal squamous cell carcinoma. Therefore, albeit they found
the shared risk variants between esophageal squamous cell
carcinoma and gastric cancer, they might miss those risk genes
which only confer risk to gastric cancer. Thus, we advocate more
genetic studies, especially GWA studies, for gastric cancer to be
carried out in the near future.
Finally, the strength of our meta-analysis could be summarized
as follows. We sought to find as many publications as we could by
means of various searching approaches. The study that appeared
to deviate from HWE was not excluded mechanically in our meta-
analysis unless there are other convincing grounds for doubting the
quality of the study [44]. We laid more emphasis on assessing
biases across studies and pinpointing the potential sources of
heterogeneity via subgroup and sensitivity analyses. We compre-
hensively assessed the publication biases using several means like
Begg’s and Egger’s tests as well as funnel plot tests. In view of this,
we convince that the results of our meta-analysis, in essence, are
sound and reliable.
Certainly, there are some unavoidable limitations in our meta-
analysis. Firstly, the offered information from the included studies
is inconsistent. Put it another way, the information about overall
gastric cancer susceptibility is predominantly provided, while more
Figure 6. Cumulative meta-analysis of associations between the IL-8 -251 AA genotype, as compared with the TT genotype, and
gastric cancer risk among Asians. Horizontal line, the accumulation of estimates as each study was added rather than the estimate of a single
study. A) sorted primarily by total number of sample size; B) sorted primarily by publication time.
doi:10.1371/journal.pone.0028083.g006
Figure 7. Funnel plot of publication bias for IL-8 -251 A/T SNP (AA vs TA). Note: Funnel plot with pseudo 95% confidence limits was used.
doi:10.1371/journal.pone.0028083.g007
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subtypes of gastric cancer is less provided. Thus, the specific
subtype results should be considered with caution. Secondly, with
the merely published studies included in our meta-analysis,
publication bias is very likely to occur, though no or a little
statistically significant publication bias is indicated in our meta-
analysis. Thirdly, moderate to severe heterogeneity could be
witnessed among the included studies. So as to minimize the
potential bias, we designed a rigorous protocol before conducting
meta-analysis, and performed a scrupulous search for published
studies using explicit methods for study selection, data extraction,
statistical analysis, adoption of the most appropriate genetic model
and sensitivity analysis.
In conclusion, IL-8 -251 AA genotype is associated with the
overall risk of developing gastric cancer and may seem to be more
susceptible to overall gastric cancer in Asian populations,
especially for Chinese Han population. IL-8 -251 AA genotype
is more associated with the intestinal-type gastric cancer. IL-8 -251
AA genotype is not associated with Helicobacter pylori infection status
in our meta-analysis.
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